Acromelic frontonasal dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1827OMIM:603671Q75.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acromelic frontonasal dysplasia (AFND) is an extremely rare congenital malformation syndrome characterized by the combination of frontonasal dysplasia (abnormal development of the front of the face and nose) and limb anomalies, particularly affecting the hands and feet (acromelic involvement). The condition is present at birth and affects multiple body systems, most prominently the craniofacial structures and the skeletal system. Key craniofacial features include widely spaced eyes (hypertelorism), a broad or bifid nasal tip, median cleft of the nose or upper lip, and sometimes central nervous system anomalies such as agenesis of the corpus callosum or encephalocele. Limb abnormalities typically include preaxial polydactyly (extra digits on the thumb or big toe side), brachydactyly (short fingers or toes), and tibial hypoplasia or aplasia. At least two genetic subtypes have been described. Acromelic frontonasal dysplasia type 1 (AFND1) is caused by pathogenic variants in the ZSWIM6 gene, while type 2 (AFND2) has been linked to variants in the NBAS gene. Both forms follow an autosomal recessive inheritance pattern. Intellectual disability of variable severity may be present in some affected individuals. Additional features can include cryptorchidism, brain malformations, and talipes equinovarus (clubfoot). There is currently no cure or disease-specific treatment for acromelic frontonasal dysplasia. Management is supportive and symptomatic, typically involving a multidisciplinary team including craniofacial surgeons, orthopedic specialists, neurologists, and developmental specialists. Surgical correction of craniofacial and limb anomalies may be undertaken depending on severity. Early developmental intervention and educational support are recommended for individuals with intellectual disability. Genetic counseling is important for affected families to understand recurrence risks.

Also known as:

Clinical phenotype terms— hover any for plain English:

Bifid nasal tipHP:0000456Preaxial foot polydactylyHP:0001841Abnormality of the glabellaHP:0002056MeningoceleHP:0002435Midline central nervous system lipomasHP:0006866Median cleft palateHP:0009099Thick nasal alaeHP:0009928Bifid noseHP:0011803
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Dec 2024Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery

Zhejiang Cancer Hospital — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Acromelic frontonasal dysplasia.

View clinical trials →

No actively recruiting trials found for Acromelic frontonasal dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Acromelic frontonasal dysplasia community →

No specialists are currently listed for Acromelic frontonasal dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acromelic frontonasal dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acromelic frontonasal dysplasiaForum →

No community posts yet. Be the first to share your experience with Acromelic frontonasal dysplasia.

Start the conversation →

Latest news about Acromelic frontonasal dysplasia

Disease timeline:

New recruiting trial: Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery

A new clinical trial is recruiting patients for Acromelic frontonasal dysplasia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Acromelic frontonasal dysplasia

What is Acromelic frontonasal dysplasia?

Acromelic frontonasal dysplasia (AFND) is an extremely rare congenital malformation syndrome characterized by the combination of frontonasal dysplasia (abnormal development of the front of the face and nose) and limb anomalies, particularly affecting the hands and feet (acromelic involvement). The condition is present at birth and affects multiple body systems, most prominently the craniofacial structures and the skeletal system. Key craniofacial features include widely spaced eyes (hypertelorism), a broad or bifid nasal tip, median cleft of the nose or upper lip, and sometimes central nervous

How is Acromelic frontonasal dysplasia inherited?

Acromelic frontonasal dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Acromelic frontonasal dysplasia typically begin?

Typical onset of Acromelic frontonasal dysplasia is neonatal. Age of onset can vary across affected individuals.